Meno Produktu: Dehydronandrolone Acetate
Synonymá: Dehydronandrolone Acetate;Dehydronandrolone-6 Acetate
CAS: 2590-41-2
MF: C20H26O3
MW: 314.42
MP: 95-98°C
Skladovacia teplota: Controlled Substance, -20°C Freezer
Vzhľad: biely prášok
Dehydronandrolone acetate is a key intermediate for the synthesis of fulvestrant (faslodex) and tibolone, while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate(CAS: 2590-41-2) is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate is an effective compound that produces quality, long-lasting muscle gains,with the biggest side effect being water retention.
| Items of analysis |
Špecifikácia |
Výsledky |
| Popis |
White to light yellow crystalline powder |
Biely kryštalický prášok |
| Bod topenia |
≥100℃ |
107℃ |
| Špecifická optická rotácia |
-20°～-26° |
-22.5° |
| Strata sušením |
≤ 0,5 % |
0.15% |
| Identifikácia |
Test preparation has maximum
absorption at 282±2nm by
ultraviolet – visible spectrophotometry. |
Qualified |
| Maximum single impurity |
≤ 1,0 % |
0.3% |
| Total impurities |
≤ 5,0 % |
0.8% |
| Skúška |
≥95,0 % |
99.45% |
| Záver |
Qualified |
